This ensures every dose is produced to the highest safety and consistency standardswhile allowing for customizations that support your health and comfort.
ACHIEVE-5 (NCT06109311) is a Phase 3, 40-week, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of orforglipron 3 mg, 12 mg and 36 mg in participants with type 2 diabetes and inadequate glycemic control with insulin glargine, with or without metformin and/or SGLT-2 inhibitors
Suggested Use: 2-4 capsules per day, in divided doses, between meals
Semaglutide mimics a naturally occurring hormone in your body called GLP-1 (glucagon-like peptide-1)
In the U.S., the Company conducts business through over 675 company-operated retail stores under The Vitamin Shoppe and Super Supplements banners and via its website, www.vitaminshoppe.com